Visit the NEW CoM Homepage |  University of Kentucky |  UK HealthCare |  Give to Medicine |  Diversity  
UK College of Medicine logo Link to the College of Medicine web site
  • ed5
  • rs3
  • cs2
  • ad4


Pharm & NS



Role of adipose tissue TGF-b signaling on adipose dysfunction in obesity

Photo of Dr. Brian Finlin, Assistant Professor,Division of EndocrinologyBrian Finlin, Ph.D.
Assistant Professor
Division of Endocrinology
Department of Internal Medicine

Obesity is associated with adipose dysfunction, which contributes to insulin resistance, diabetes, and heart disease.  It has been proposed that adipose dysfunction is caused by an inappropriate response to hypoxia that results in increased ECM expression and reduced angiogenesis.  Our data indicate that adipocyte-macrophage cross talk results in increased expression of thrombospondin-1 (TSP-1), a multifunctional protein that promotes fibrosis by activating TGF-beta signaling.  TGF-beta has multiple effects on adipose in addition to inducing fibrosis including inhibiting adipogenesis and complicated effects on angiogenesis. Recently, a whole-body knockout of SMAD3 to block TGF-beta signaling resulted in mice with improved metabolic function and browning of their white adipose; this was due in part to reversing the inhibition of TGF-beta on the expression of PGC-1 alpha.  Our overall hypothesis is that increased TSP-1 expression and TGF-beta signaling in white adipose with obesity cause increased fibrosis, reduced capillary density, reduced PGC-1 alpha and reduced UCP-1 expression hence less “browning”, and impaired WAT function.  Thus, inhibiting the TGF-beta pathway in humans may improve adipose function and reverse the effects of obesity on insulin resistance.  The first aim will characterize the white adipose ECM and capillary density of TSP-1 knockout mice and their littermate controls challenged with a high fat diet.  The second aim will knockout TGF-beta in adipose using cre/lox technology to elucidate the role of TGF-beta signaling on adipose function is response to high fat feeding.  The third aim will determine whether the dramatic reduction in adipocyte PGC-1 alpha by macrophage coculture is TGF-beta dependent.  The fourth aim will determine whether toll-like receptor (TLR) signaling is involved in the adipocyte-macrophage crosstalk that induces TSP-1 and TGF-beta signaling in macrophages.  Thus, the two mouse models will indicate the contribution of TSP-1 and TGF- beta to adipose dysfunction with obesity.  The coculture studies will begin to define the mechanisms by which adipocytes and macrophages communicate with each other to induce TSP-1 expression by both cells types and to decrease PGC-1 alpha expression in adipocytes.


Photo of Dr. Gregory Graf, Professor, Pharmaceutical SciencesGregory Graf, Ph.D.
Associate Professor
Department of Pharmaceutical Sciences





Lisa R.Tannock, M.D. Lisa R. Tannock
Associate Professor
Chief, Division of Endocrinology & Molecular Medicine





Shuxia Wang, M.D., Ph.D. Suxia Wang
Associate Professor
Pharmacology and Nutritional Sciences
Department of Internal Medicine, College of Medicine





Deneys van der Westhuyzen, PhD
Department of Molecular and Cellular Biochemistry

Comments and Corrections |  An Equal Opportunity University |  Jobs  |  Terms, Conditions and Accessibility Statements   |  Privacy
© 2012, University of Kentucky College of Medicine, 138 Leader Ave., Lexington, Kentucky, USA 40506-9983
Student Affairs: (859) 323-5261 · Admissions: (859) 323-6161 · Clinical Questions: (859) 257-1000 · Dean's Office: (859) 323-6582
Page last updated Tuesday, November 18, 2014